Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Figure S2 from Combination Therapy Targeting Ribosome Biogenesis and mRNA Translation Synergistically Extends Survival in MYC-Driven Lymphoma
  1. Home
  2. Publications
  3. Supplementary Figure S2 from Combination Therapy Targeting Ribosome Biogenesis and mRNA Translation Synergistically Extends Survival in MYC-Driven Lymphoma

Supplementary Figure S2 from Combination Therapy Targeting Ribosome Biogenesis and mRNA Translation Synergistically Extends Survival in MYC-Driven Lymphoma

Authors:
  • JDJennifer R. Devlin
    Jennifer R. Devlin
  • KHKatherine M. Hannan
    Katherine M. Hannan
  • NHNadine Hein
    Nadine Hein
  • CCCarleen Cullinane
    Carleen Cullinane
  • EKEric Kusnadi
    Eric Kusnadi
  • PNPui Yee Ng
    Pui Yee Ng
  • Amee J. George
    Amee J. George
  • JSJake Shortt
    Jake Shortt
  • MBMegan J. Bywater
    Megan J. Bywater
  • GPGretchen Poortinga
    Gretchen Poortinga
  • Elaine Sanij
    Elaine Sanij
  • JKJian Kang
    Jian Kang

Open Access
Publisher website
Google Scholar
  • 3 April 2023
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/2159-8290.22530956
Abstract
No abstract available
Keywords
  • RIBOSOME BIOGENESIS
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.